Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart drug safety checked in 8 japanese kids

NCT ID NCT06149104

Completed Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 23 times

Summary

This study looked at the safety of the heart failure drug sacubitril/valsartan in Japanese children under 18 who had already finished a previous study. The goal was to collect more safety information and give these children access to the drug until a child-friendly version is available in Japan. Only 8 children took part, and the main focus was tracking any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    Ōbu, Aichi-ken, 474 8710, Japan

  • Novartis Investigative Site

    Ōmura, Nagasaki, 856-8562, Japan

  • Novartis Investigative Site

    Bunkyo Ku, Tokyo, 113 8655, Japan

  • Novartis Investigative Site

    Setagaya-ku, Tokyo, 157-8535, Japan

  • Novartis Investigative Site

    Saitama, 330 8777, Japan

  • Novartis Investigative Site

    Toyama, 930-0194, Japan

Conditions

Explore the condition pages connected to this study.

HEART FAILURE